key: cord-1044066-aqz204ge
authors: Shu, Lei; Wang, Xiaoyan; Li, Mingquan; Chen, Xiaolin; Ji, Ningfei; Shi, Lei; Wu, Mingjing; Deng, Kaili; Wei, Jing; Wang, Xueli; Cao, Yang; Yan, Jiaxin; Feng, Ganzhu
title: Clinical characteristics of moderate COVID‐19 patients aggravation in Wuhan Stadium Cabin Hospital: A 571 cases of retrospective cohort study
date: 2020-08-16
journal: J Med Virol
DOI: 10.1002/jmv.26414
sha: db4e19b801753b275b267400a9db9c760fd844fb
doc_id: 1044066
cord_uid: aqz204ge

To report the clinical characteristics and potential risk factors of patients with coronavirus disease 2019 (COVID‐19) in Wuhan Stadium Cabin Hospital in Hubei Province. A total of 571 patients of COVID‐19 treated in the Wuhan Stadium Cabin Hospital were selected for analysis, univariable and multivariable logistic regression methods were used to explore the risk factors associated with disease aggravation. The main clinical symptoms of moderate COVID‐19 were fever, cough and dyspnea, hypertension, diabetes, and coronary heart diseases were the main comorbidities both in transferred and stable patients. Twenty‐six patients (4.55%) of mild and moderate patients had disease aggravation, and most of which occurred between 36 and 48 hours after admission. Multiple regression analysis showed increasing odds of disease aggravation associated with former smoker history, diabetes, dyspnea, consolidation, and interstitial abnormalities of computed tomography scanning, lymphopenia and elevated of C‐reactive protein, the time points of transferred patients mainly between 36 and 48 hours (65.38%), and the average hospital stay for stable patients was 15 days.It could help clinicians to identify patients with poor prognosis at an early stage, and provide early warning role for timely intervention.

infectious disease according to the Law of the People's Republic of China on the prevention and control of infectious diseases and managed as Class A infectious disease. 3 At the same time, The World Health Organization (WHO) has recently declared COVID-19 as a public health emergency of international concern, 4 which indicating this COVID-19 poses a huge threat to global health.

To solve the problem of difficult hospitalization of the patients, By the end of February, the Chinese government totally opened 14 Cabin Hospitals to treat patients confirmed with mild or moderate of COVID-19. With the effective intervention measures and isolation plans formulated by the government in an efficient manner, most patients received timely diagnosis and treatment.

Since the outbreak of COVID-19, lots of basic, clinical and epidemiological studies have been reported successively, [5] [6] [7] [8] and the severity of some cases of COVID-19 mimicked that of severe acute respiratory syndrome coronavirus (SARS-CoV), 6, 9 however, there is no special study on the clinical characteristics of patients and potential risk factors for disease aggravation in Cabin hospital. As a centralized admission hospital for treating COVID-19, we have treated 571 patients were diagnosed of COVID-19. This study intends to summarize and analyze the clinical characteristics of the above-mentioned patients, and explore the risk factors for disease aggravation, and hope to help clinicians to identify patients with poor prognosis at an early stage, and provide early warning function for timely intervention.

This was single-center, retrospective cohort study, and the general information, epidemiological history, incidence, clinical manifestations, laboratory parameters, imaging examinations and treatment of patients confirmed COVID-19 pneumonia were admitted in Wuhan Stadium Cabin Hospital, the study was approved by the Ethics Committee of Wuhan Stadium Cabin Hospital, and the written informed consent was waived because of the retrospective nature of the study and belongs to emergency medical service. (2) History of contact with new coronavirus infected persons (positive nucleic acid test) within 14 days before onset;

(3) Have been exposed to patients with fever or respiratory symptoms from Wuhan and surrounding areas, or from communities with case reports;

(4) Cluster of diseases.

(1) Fever and /or respiratory symptoms;

(2) Imaging characteristics of pneumonia: multiple small patchy shadows and interstitial changes in the early stage, subsequently developed into bilateral ground-glass opacity, infiltrates in both lungs. In severe cases, pulmonary consolidation may occur with little pleural effusion;

(3) Total number of white blood cells in the early stage of disease was normal or decreased, and the lymphocyte count was decreased.

According to the guideline of New coronavirus pneumonia diagnosis and treatment program, the confirmed patients were divided into the (Table S1 ).

Continuous variables with normal distribution were expressed as mean ± standard deviation; non-normal continuous variables were reported as median (interquartile range [IQR] ). For P value, the Mann-Whitney U test were used for analyzing the normally distributed continuous variables, and the Kruskal-Wallis test for nonnormally distributed data. The categorical variables were presented as percentage and analyzed by the χ 2 test or the Wilcoxon rank-sum test. All statistical analyses were performed with Stata version 14.2 for Mac (StataCorp, College Station, TX), and P value less than .05 was considered statistically significant. Multiple logistic regression models were used to identify factors that influenced outcomes and presented as odds ratios (ORs) and 95% confidence intervals (CIs).

The differences in baseline characteristics among nonanemic and anemic patients entered into the multivariate regression. Results were reported follow that all associations as ORs in logistic regression models, with their corresponding 95% CIs. Laboratory results showed the white blood cell count, neutrophils and lymphocytes were all lower in transferred patients than stable patients, whereas, lactate dehydrogenase (LDH) and C-reactive protein (CRP) were both in significantly higher in transferred patients than stable patients. No significant difference of the other laboratory results between in the two groups patients (Table 2 ).

In univariable analysis, odds of disease aggravation were higher with diabetes or coronary heart disease or hypertension (Table 1) .

Former smoker history, lymphopenia, LDH, and CRP were also associated with disease aggravation (Tables 1 and 2) .

We included 571 patients with complete data for all variables (26 transferred patients and 545 stable patients) in the multivariable logistic regression model. We found that former smoker history, diabetes, dyspnea, consolidation, and interstitial abnormalities of CT scanning, lymphopenia, and elevated of CRP were associated with increased odds of disease aggravation (Table 3) . sneezing, and sore throat are not common, which are different from the previously reported SARS and MERS related onset symptoms. 13, 14 Older age has been reported as an important independent predictor of mortality not only in SARS and MERS, 15, 16 but also in COVID-19, 17 however, in our study, age was not a risk factor for disease aggravation, this may be related to the majority of mild and moderate patients admitted to the cabin hospital.

Although smoking history was not an independent risk factor for disease exacerbations in previous studies, however, in our multivariate regression analysis, former smoker history was associated with disease aggravation, which may have an impact on breathing, and further research is needed to determine whether smoking is an independent risk factor for assessing of disease prognosis.

It is well known that diabetes is an independent risk factor for a variety of diseases, in previous studies, diabetes was considered as a risk factor for disease exacerbation of COVID-19, 18,19 through our regression analysis, it was also found that patients with diabetes had higher rate of transferred, previous data suggested that ACE2 expression was increased in diabetes and treatment with ACE inhibitors and ARBs increased ACE2 expression, however, whether the specific mechanism of diabetes affecting prognosis of COVID-19 through the expression of ACE2 still need further study.

Our study has some limitations. First, due to the retrospective study design, not all laboratory tests were done in all patients, which might be underestimated in predicting disease condition. Second, the results and prognosis of 26 patients were unknown due to transferred to a designated specialized hospital for further treatment, last but not least, interpretation of our findings might be limited by the sample size. However, by including the number of cases in cabin hospital, we believe our study population is representative disease condition of mild and moderate of COVID-19.

In summary, we hope the potential risk factors of former smoker history, diabetes, dyspnea, consolidation and interstitial abnormalities of CT scanning, lymphopenia and elevated of CRP could help clinicians to identify patients with poor prognosis at an early stage, and provide early warning function for timely intervention.

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission

Findings in 2019 novel coronavirus (2019-nCoV) infections from Wuhan, China: key points for the radiologist

World Health Organization. Coronavirus disease (COVID-19) outbreak

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

Emerging coronaviruses: genome structure, replication, and pathogenesis

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance

World Health Organization. Coronavirus disease (COVID-19) technical guidance: laboratory testing for 2019-nCoV in humans

A major outbreak of severe acute respiratory syndrome in Hong Kong

Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study

Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong

Predictors of mortality in Middle East respiratory syndrome (MERS)

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a singlecentered, retrospective, observational study

Clinical characteristics of moderate COVID-19 patients aggravation in Wuhan Stadium Cabin Hospital: A 571 cases of retrospective cohort study

The authors thank the authors of the primary studies for their timely and helpful responses to our information requests. This work was supported by grant of National Natural Science Foundation of China 

The authors declare that there are no conflict of interests.

LS, NJ, and GF conceived and designed the study, and take responsibility for the integrity of the data and the accuracy of the data analysis. 

The data used to support the findings of this study are available from the corresponding author upon request.

This study was approved by the Institutional Review Board of Wuhan Stadium Cabin Hospital. All data were anonymized to comply with the provisions of personal data protection legislation. The written informed consent was waived because of the retrospective nature of the study and belongs to emergency medical service.

https://orcid.org/0000-0003-0505-9506